The Europe over the counter (OTC) drugs market is witnessing steady growth driven by rising self-medication trends, increasing healthcare awareness, and easy product accessibility. The market is expected to reach USD 25.55 billion by 2035, expanding at a CAGR of 5.50%.

Europe Over the Counter (OTC) Drugs Market Statical Scope

In Europe, the over-the-counter (OTC) drugs market is experiencing growth attributed to the rising incidence of chronic and lifestyle-related conditions, including diabetes, cardiovascular diseases, arthritis, and obesity. Additionally, the growing prevalence of respiratory diseases and seasonal allergies, particularly in Northern and Western Europe, is further amplifying the demand for OTC products such as cough syrups, cold and flu remedies, and antihistamines. There is also a notable increase in focus on women's health, driving demand for OTC solutions specifically addressing reproductive health, menopause management, and nutritional needs.

Europe Over the Counter (OTC) Drugs Market Share, By Product Type, 2025 (%)

• Analgesics- Analgesics dominate the segment, with a 27% share, driven by high consumer demand for pain relief medications used for headaches, muscle pain, and chronic discomfort management.
• Cold & Cough Remedies- Cold & cough remedies hold a significant 22% share, supported by seasonal illnesses, widespread respiratory infections, and strong OTC accessibility.
• Vitamins & Minerals- Vitamins & minerals account for a notable share of 20%, driven by increasing health awareness and rising use of dietary supplements.
• Digestives & Intestinal Remedies- The digestives & intestinal remedies segment holds a share of 14%, supported by the growing prevalence of digestive disorders and lifestyle-related gastrointestinal issues.
• Skin Treatment- Skin Treatment products hold a 17% share, driven by demand for OTC solutions addressing minor dermatological conditions and skincare needs.

Europe Over the Counter (OTC) Drugs Market Share, By Distribution Channel, 2025 (%)

• Drug Stores & Retail Pharmacies- Drug stores & retail pharmacies dominate the segment, with a share of 62%, driven by easy accessibility, consumer trust, and widespread availability of OTC medicines.
• Online Pharmacies- Online Pharmacies hold a growing share of 28%, supported by rising digital adoption, convenience and expanding e-commerce penetration in healthcare.
• Hospital Pharmacies- Hospital Pharmacies account for a share of 10%, primarily driven by post-treatment OTC dispensing and institutional healthcare needs.

Top Companies in the Europe Over the Counter (OTC) Drugs Market

• Johnson & Johnson Services Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• Pfizer
• GlaxoSmithKline Plc
• Boehringer Ingelheim International GmbH
• Reckitt Benckiser Group PLC
• Takeda Pharmaceutical Company Ltd.
• Perrigo Company plc

Segments Covered in the Report

By Product Type

• Analgesics
• Cold & Cough Remedies
• Digestives & Intestinal Remedies
• Skin Treatment
• Vitamins & Minerals
• Others

By Distribution Channel

• Drug Stores & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies